Target intelligence / Profile preview

MT-ND3 pseudogene 20 (MTND3P20)

Target
MTND3P20
Molecular classification
Other (Pseudogene; mitochondrial-derived non-coding sequence)
01

Overview

MT-ND3 pseudogene 20 (MTND3P20) is a nuclear pseudogene corresponding to the mitochondrial gene MT-ND3, which encodes NADH dehydrogenase 3, a subunit of mitochondrial respiratory chain complex I. MTND3P20 itself is a non-coding sequence that does not produce a functional protein and is not a therapeutic target. Pseudogenes such as MTND3P20 may have regulatory roles or serve as markers in genomic studies, but there is no direct evidence or established function for this pseudogene in health or disease. The canonical, protein-coding MT-ND3 gene is important for mitochondrial oxidative phosphorylation and has known disease associations (e.g., Leigh syndrome, MELAS), but those are not attributed to MTND3P20[1][3][4]. MTND3P20 is a pseudogene, not a protein-coding gene or therapeutic target. It is primarily a genomic element with no known function, drug interactions, biomarker status, or safety concerns. Its clinical and biological relevance appears limited, and its presence may only be pertinent in bioinformatic or regulatory context rather than as a molecular target for intervention[4].

Other names
MTND3P20MT-ND3 pseudogene 20mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 20
02

Mechanism of action

None. No mechanism of action is described for drugs or therapies targeting this pseudogene.

03

Biological functions

None established for the pseudogene itself; does not encode a functional protein.
04

Disease associations

There is currently no direct link between MTND3P20, as a pseudogene, and any specific disease states. However, related pseudogenes and altered expression of pseudogenes have been studied for their potential regulatory roles in neurodegenerative diseases, though MTND3P20 itself is not mentioned directly in literature for disease roles[4].
05

Safety considerations

None specific; as a pseudogene, MTND3P20 is not an active therapeutic target.
06

Interacting drugs

None. There are no drugs known to target or interact with MTND3P20.
07

Biomarkers

None linked directly to MTND3P20.

Beyond the preview

Go deeper on MT-ND3 pseudogene 20 (MTND3P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND3 pseudogene 20 (MTND3P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call